| Literature DB >> 36233693 |
Li-Ching Chang1,2.
Abstract
Dental implant therapy is a common clinical procedure for the restoration of missing teeth. Many methods have been used to promote osseointegration for successful implant therapy, including photofunctionalization (PhF), which is defined as the modification of titanium surfaces after ultraviolet treatment. It includes the alteration of the physicochemical properties and the enhancement of biological capabilities, which can alter the surface wettability and eliminate hydrocarbons from the implant surface by a biological aging process. PhF can also enhance cellular migration, attachment, and proliferation, thereby promoting osseointegration and coronal soft tissue seal. However, PhF did not overcome the dental implant challenge of oral cancer cases. It is necessary to have more clinical trials focused on complex implant cases and non-dental fields in the future.Entities:
Keywords: bone–implant interface; dental implant; osseointegration; ultraviolet
Year: 2022 PMID: 36233693 PMCID: PMC9571244 DOI: 10.3390/jcm11195823
Source DB: PubMed Journal: J Clin Med ISSN: 2077-0383 Impact factor: 4.964
The effect of photofunctionalization on dental implants in vitro.
| Author | Material | Method | Results with UV Treatment |
|---|---|---|---|
| To Reverse the Biological Aging/Degradation of Implant Surface | |||
| Iwasa F et al. | Ti with micro-nano-hybrid topography vs. Ti with | UV using a 15 W bacterial lamp for 48 h Stored for 8 weeks, then the PhF of a fresh, 3-day-old and 7-day-old UV-treated implant surface |
Slower rate of the time-dependent degradation of titanium bioactivity after UV treatment in micro-nano-hybrid topography implant compared to that in microtopography alone |
| Tuna T et al. | Zirconia-based discs Smooth vs. rough surfaces | UV using TheraBeam® Affiny for 15 min |
To decrease carbon by 43–81% To increase oxygen by 19–45% and zirconia by 9–41% To change from hydrophobic to hydrophilic No topographic change |
| Roy M et al. | Commercial osteoplant base and rapid titanium dental implants | UVC with TheraBeam® SuperOsseo for 12 min |
To reverse the biological aging of titanium by reducing carbon contamination (up to 4-fold) To reduce surface H2O To increase TiOH with many -OH groups To improve biologic results No change in the topography of the surface |
| Roy M et al. | ZrO2 (Zr similar to titanium) | UVC with TheraBeam® SuperOsseo for 12 min |
To reduce carbon 3-fold No change in crystalline structure |
| Arroyo-Lamas N et al. | Ti with Ti oxide surface | UVC for 12 min |
To reduce the concentration of surface hydrocarbons (26~23.4 C at %) To increase the concentration of O2 and Ti Hg-vapor lamps could be replaced by LED-based technology |
| Roy M et al. | TiO2, ZrO2, polyether-ether-ketone (PEEK) | UVC using TheraBeam® SuperOsseo for 12 min |
To remove hydrocarbons (twofold in PEEK; threefold in TiO2 and ZrO2) To decrease the harmful effect of the biological aging of the implant surface |
| Jaikumar RA et al. | Zirconia implant | UV (λ = 254 nm) for 48 h |
UV group vs. control group: Oxygen concentration: 42.8% vs. 29.09% carbon concentration: 34.34% vs. 45.41% To enhance the surface topography and hydrophilicity |
| To decrease peri-implant stress distribution | |||
| Ohyama T et al. | 3-dimensional finite element analysis of different lengths with various BICs (53.0% and 98.2%) | BIC 98.2% as UV treatment |
To diminish peri-implant stress by 50% (BIC 98.2% vs. 53.0%); 15% (implant length from 7 to 13 mm) To improve the effective distribution of peri-implant stress rather than implant length Similar results under oblique load |
| Ohyama T et al. | Unique finite element analysis model with a 3D model | BIC 98.2% as UV treatment |
To reduce stress on surrounding tissues UV treatment vs. wider implants: Greater effect in vertical loading Less effect in oblique loading |
| Antimicrobial effect | |||
| Yamada Y et al. | Wound pathogens such as | UVA (λ = 352 +/− 20 nm) or |
To decrease the amount of bacterial attachment and accumulation To change wettability, as per the modification to a super hydrophilic surface To reduce carbon content (UV-C better than UV-A in the above items) No change in topography |
| De Avila ED et al. | Titanium disc | UVC using TheraBeam® SuperOsseo for 12 min |
To create and maintain an antimicrobial surface To change the bacterial community profile To reduce bacterial attachment and biofilm formation |
| Jain S et al. | Streptococcus sanguinis | 15 W UVA |
To reduce bacterial attachment by at least 20% Achieve at least 50% killing efficacy by UVA in an anodized layer with an anatase phase Achieve at least 50% killing efficacy by UVA or UVC in an anodized layer with anatase and rutile phases. |
| Different cell studies | |||
| Shen JW et al. | MC3T3-E1 cells | UV using a 15 W bacterial lamp for 24 h |
To remove hydrocarbon contamination on titanium stored in air or water To increase cell attachment, proliferation, ALP activity, and osteocalcin release |
| Henningsen A et al. | Murine osteoblasts Sandblasted and acid-etched titanium discs | UVC using TheraBeam® SuperOsseo for 12 min |
To increase the oxidation of the surface To decrease the carbon on the surface No change in surface structure To promote osteoblast attachment and growth. |
| Ikeda T et al. | Osteoblasts derived from rat bone marrow | UV treatment |
To decrease bioactivity when the temperature fluctuates by ≥20 °C above or below room temperature (25 °C) (particularly toward lower temperatures), independent of the hydrophilicity/ hydrophobicity To restore temperature-compromised bioactivity using UV treatment |
| Mehl C et al. | Gingival fibroblast | UVC using TheraBeam® SuperOsseo for 12 min |
To increase cell adhesion on zirconium dioxide by UV, argon plasma, or ultrasound disinfection To increase cell adhesion on a titanium alloy with ultrasound disinfection |
| Harder S et al. | Human whole blood | UVC using TheraBeam® SuperOsseo for 12 min |
To suppress the gene expression of IL 1β for 1–8 h (TNF gene not significantly altered). |
| Nakhaei K et al. | Human epithelial cells | UVC using TheraBeam® SuperOsseo for 12 min |
To remove carbon contamination by reducing C-C and C = O groups To enhance the attachment, adhesion, and retention of epithelial cells on implants |
| Okubo T et al. | Human epithelial cells | UVC using TheraBeam SuperOsseo for 12 min |
To remove the chemical contamination of the polished surface To increase the number of attached epithelial cells on the implant To increase the number of adherent cells after mechanical detachment |
| Razali M et al. | Human gingival keratinocytes and fibroblasts | UVC using Therabeam® SuperOsseo for 12 min. |
To improve the biological seal of the surrounding soft tissue peri-implant interface Yttria-stabilized zirconia with the best biological seal among these materials |
ALP: alkaline phosphatase; BIC: bone-to-implant contact; SLA: sandblasted acid-etched; Ti: titanium; UV: ultraviolet; UVA: ultraviolet A; UVC: ultraviolet C; 3D: three dimensions. PEEK: please to see material (polyether-ether-ketone). LEDs: Light-emitting diodes.
Preclinical animal studies of photofunctionization.
| Author | Material | UV Light | Results with UV Treatment |
|---|---|---|---|
| Rat model | |||
| Aita H et al. | Machined and acid-etched Ti | UVA/UVC for variable time up to 48 h |
To enhance osteoconductive capacity To accelerate implant fixation 4-fold |
| Ikeda T et al. | Nanofeatured Ti | UV-T for 15 min using TheraBeam Affiny |
To improve the strength of osseointegration by a push-in test (2.2-fold in week 2 and 2.3-fold in week 4 of healing) |
| Sugita Y et al. | Ti femurs of 10 genetically modified rats (phenotype close to human type 2 diabetes; 10 weeks old) | UV for 15 min using TheraBeam Affiny |
To increase the strength of osseointegration (1.8-fold in week 2 and 3-fold in week 4 of healing) in a rat model of type 2 diabetes |
| Minamikawa H et al. | Ti6Al4V (smooth or rough surface) | UV-T for 15 min using TheraBeam Affiny |
To convert the Ti6Al4V surface from hydrophobic to super-hydrophilic (however, the conversion to hydrophobic takes 4 weeks) To improve the strength of the bone–implant integration of both surfaces (UV treatment on a smooth surface > no treatment on a rough surface) |
| Tabuchi M et al. | Ti-6Al-4V mini-screw Femurs of 6 rats | UV for 12 min using TheraBeam SuperOsseo device |
To change from hydrophobic to super-hydrophilic To increase resistance against the tipping force by 1.5~1.7-fold To gain a strong elemental peak of calcium and phosphorus |
| Tabuchi M et al. | Ti-6Al-4V mini-screw Femurs of 6 rats | UV for 12 min using TheraBeam SuperOsseo |
To improve anchoring capability Less displacement under lateral tipping force More intact and contiguous regenerated bone tissue |
| Brezavscek M et al. | Zirconia-based disc | Push-in test (48 rats) |
To increase push-in values at Week 2 by 2.1–2.8-fold and at Week 4 by 1.7–2.0 fold To increase the BIC on a smooth surface by 3~7-fold and on a rough surface by 1.4~1.7-fold To enhance the strength of the bone–implant interface by 2-fold (40 rats) |
| Ishijima M et al. | Ti mini-implants | UV for 12 min using TheraBeam SuperOsseo |
To enhance the strength of osseointegration by 40% in aged rats Strong elemental peaks of calcium and phosphorus |
| Hirota M et al. | Acid-etched Ti implants | Half of implants in 2 mm defect, half exposed |
To enhance vertical ridge augmentation and bone–implant contact To increase the strength of osseointegration (3-fold) To enhance the closure of the bone–implant gap |
| Soltanzadeh P et al. | Ti implants | 0.46 N of constant lateral force |
To increase the success rate (100% vs. 28.6%) To increase the strength of osseointegration (2.4-fold) To decrease the implant title degrees (0.5-fold) |
| Taniyama T et al. | Ti implants (1 × 2 mm) | Rat osteoporosis model |
Titanium with vs. without UV treatment: Contact angle of H2O: </=5 degrees vs. >/=80 degrees To enhance bone–implant integration in ovariectomized rats (80% higher than control titanium) To increase the push-in value in both groups by 50–70% |
| Rabbit model | |||
| Sawase T et al. | Ti implant with the anatase form of a TiO2 surface | UV for 24 h |
To improve initial cell reactions To enhance early bone formation by increasing BIC |
| Jimbo R et al. | Fluoride-modified TiUnite implants | UV (352 nm) for 24 h |
To enhance BIC and bone apposition during early stages of osseointegration (2 and 6 weeks) |
| Hayashi M et al. | TiO2 powder spin-coated onto pure titanium disc | UV (352 nm, 6 W) for 24 h |
To upregulate gene expression (ALP, RUNX-2, and IL-10) To continue the biologically enhancing effect even after 12 weeks of healing time |
| Yamazaki M et al. | Acid-etched pure titanium screws | UVC (3 mW/cm2) for 48 h using a 15 W bactericidal UV bench lamp (254 nm) |
To gain a higher density of cells, as well as thicker and longer bone tissue attachments To increase the volume of cortical-like tissue in the coronal region |
| Shen J et al. | Ti implants (4 × 8 mm) | 32 implants × 5 groups: |
To eliminate hydrocarbon contamination To enhance bone-to-implant contact (interfacial strength) and osseointegration |
| Kim HS et al. | Commercial Ti implants | ALN on titanium surface |
To increase per-implant bone formation and osseointegration Highest bone–implant contact in the UV+/ALN+ group |
| Lee JB et al. | Machined SLA surface Ti implants | UVC for 48 h |
Higher bone-to-implant contact ratio at 10 days To gain earlier osseointegration in a machined surface implant after UV treatment than in an SLA surface implant |
| Sanchez-Perez A et al. | 20 commercial Titanium implants (3.75 × 8 mm) | UVC-lamp (254 nm; 6 W) |
Did not improve the percentage of BIC at 8 weeks More homogenous BIC values in the UV group |
| Yin C et al. | 3D-printed porous Ti6Al4V scaffolds in a dark place for 4 weeks | A irradiation cube: >2 MW/cm2 (270 nm) and 30 MW/cm2 (365 nm) for 15 min |
To enhance hydrophilicity, cytocompatibility, and alkaline phosphatase activity, while preserving their original mechanical properties in vitro To promote bone ingrowth, the bone–implant contact ratio, and the mineralized/osteoid bone ratio in vivo |
| Dog model | |||
| Hirakawa Y et al. | Ti implants with TiO2 surface | Plasma source ion implantation method |
To improve serum fibronectin attachment To increase BIC after 2 weeks healing (42.7% vs. 28.4% in control) To accelerate early osseointegration by a combination of plasma fibronectin and plasma source ion implantation |
| Pyo SW et al. | Commercial Ti implants | UV for 15 min using TheraBeam Affiny |
To convert an implant surface from hydrophobic to super-hydrophilic To increase removal torque by 50% and BIC To promote interfacial bone deposition and marginal bone seal |
| Kim MY et al. | Ti implants | 2 as control vs. 2 as UV |
To gain better osseointegration To increase bone-to-implant contact (BIC) and new bone formation |
| Huang Y et al. | Aged Ti-implant | 12 as control |
There were significantly higher BV/TV and bone–implant contact at 4 weeks; however, there were no significant differences at 12 weeks. The effect was independent on the UV-C duration. |
| Minipig model | |||
| Mehl C et al. | 48 titanium implants | UVC for 48 h |
To attain higher earlier osseointegration No significant differences in bone–implant contact (BIC) and implant stability quotient (ISQ) in 9 months |
ALN: alendronate; BIC: bone-to implant contact; BV/TV: trabecular bone volume to total volume fraction; IL-10: interleukin-10; ISQ: implant stability quotients; RUNX-2: runt-related transcription factors 2; Ti: titanium; UV: ultraviolet; UVA: ultraviolet A; UVC: ultraviolet C.
Clinical studies of dental implant therapy using photofunctionization.
| Author | Study Type | Material and Method | Results with UV Treatment |
|---|---|---|---|
| I-1. Dentistry | |||
| Ogawa T. Study Group (Japan) | |||
| Funato A et al. | Case series |
7 implants (3i Biomet, Certain) in the compromised bone of four patients UV machine (TheraBeam Affiny; Ushio Inc., Tokyo, Japan): UV treatment for 15 min |
Complex cases: fresh extraction socket, sinus elevation, vertical ridge augmentation, and the immediate replacement of failing implant ISQs from 48–75 at placement to 68–81 at loading To gain more ISQ between implant placement and loading in cases with lower primary stability To increase or to maintain marginal bone level at one year after loading PhF enhanced OSI (increased ISQ per month) in complex cases PhF shortened osseointegration time |
| Funato A et al. | Retrospective study |
168 implants in 70 patients (with UV treatment) vs. 222 implants in 95 patients (without UV treatment) UV machine (TheraBeam Affiny; Ushio Inc. Tokyo, Japan): UV treatment for 15 min |
To shorten healing time before loading: 3.2 months vs. 6.5 months To promote “OSI” in different primary stability subgroups: “2.0–8.7” vs.”1.8–2.8” Similar implant survival rate: 97.6% vs. 96.3% PhF allowed for a faster loading protocol without compromising the implant success rate |
| Suzuki S et al. | Prospective study |
33 implants (NobleReplace, TiUnite) in the maxilla of 7 patients UV machine (TheraBeam Affiny; Ushio Inc. Tokyo, Japan): UV treatment for 15 min |
To increase ISQ in UV treatment groups: eliminating stability dip, 78.0 at 6 weeks vs. 66.1 at 2~6 months in “literature as-received implants” To promote OSI in UV treatment groups: 6.3 in “initial ISQ from 65 to 70” and 3.1 in “initial ISQ from 70 to 75” vs. −3.0 to 1.17(average: -0.10) in “literature as-received implants” PhF accelerated and enhanced the osseointegration of dental implants |
| Kitajima H et al. | Retrospective study |
55 implants (3i Biomet, Certain) in 38 patients with ISQs < 60 at placement UV machine (TheraBeam Affiny; Ushio Inc. Tokyo, Japan): UV treatment for 15 min |
190.9% implants in complex cases: GBR, sinus lift or fresh extraction sockets; 9.1% in regular cases Implant success rate: 98.2% after 2–3 years follow-up To increase in ISQs from 50.4 +/− 7.7 at placement to 74.3 +/− 5.7 at Stage II surgery; average healing time 7.1 +/− 2.1 months OSI (OSI as “ISQ at Stage II–ISQ at placement/healing time”) of low initial-stability implants (ISQs < 55): 3.9–4.7 in the UV group vs. 0.36–2.8 in the as-received group PhF was more effective for implants with lower primary stability |
| Hirota M et al. | Retrospective case-control study |
49 implants (Branemark MKIII TiUnite) in 7 patients; 24 as-received and 25 with UV treatment UV machine (TheraBeam Affiny; Ushio Inc. Tokyo, Japan): UV treatment for 15 min |
Complex cases: GBR, sinus lift, fresh extraction sockets To accelerate OSI both for regular and complex cases, especially more pronounced in cases with poor quality bone and complex cases To increase final ISQ at Stage II in the UV group regardless of primary stability and innate bone support at implant placement PhF was a stronger determinant of implant stability than other factors |
| Hirota M et al. | Retrospective study |
563 implants in 219 patients Bone quality classification with CT Hounsfield unit (HU): D1~D4 UV machine (TheraBeam Affiny; Ushio Inc., Tokyo, Japan): UV treatment for 15 min |
D1: >1250 HU; D2: 750–1250 HU; D3: 375–750 HU; D4: 150–375 HU Early implant failure rate: subjects with UV treatment vs. subjects without UV treatment: 1.3% vs. 4.3% To reduce the early implant failure rate after UV treatment |
| Hirota M et al. | Prospective study |
70 implants in 16 patients for follow-up after 7 years, including regular cases, complex cases, and cancer-related patients Bone quality classification with CT Hounsfield unit (HU): D1~D5 CT, bone quantity: A~E UV machine (TheraBeam Affiny; Ushio Inc. Tokyo, Japan): UV treatment for 15 min, then cleaning ozone for 5 min |
Regular (no site development or cancer): 30 implants into analysis + 4 implants in sleep; Complex (GBR, sinus lift, fresh extraction sockets): 21 implants; Cancer (cancer-related resection +/− radiation): 15 implants Success rate in regular cases, complex cases, and cancer-related patients: 100%, 100% and 22.2% Did not overcome the challenges of a pathophysiologically compromised oral condition |
| I-2. Other study groups | |||
| Puisys A et al. | Triple-blinded, split-mouth, randomized controlled clinical trial |
360 implants in 180 patients; 180 (UV; 71 in maxilla, 109 in mandible) vs. 180 (control; 71 in maxilla, 109 in mandible) Placement; Groups 1~6 (weeks 1, 2, 3, 4, 6, and 8) UV device (TheraBeam SuperOsseo; Ushio Inc., Sazuchi Bessho-cho, Himejij, Hyogo, Japan): for 12 min wavelength: 180–300 nm |
To increase the RT value (indirect information of BIC) Significant difference in the RT value between UV and control: in groups 2, 3, 4, and 6. To improve healing and implant stability, especially in the early phase To increase the speed of osseointegration |
| Choi B et al. | Parallel-designed randomized double-blinded clinical trial | 57 implants in the posterior maxilla of 34 patients; 29 (UV) vs. 28 (control) CBCT grayscale value: |
Group III: significant difference in ISQ at 4 weeks and 4 months Group II: significantly less bone loss in the UV-treatment group at 4 weeks Others: no significant difference between the UV-treatment and the control group To increase initial stability in posterior maxilla with poor bone density To allow a faster loading protocol |
| Shah SA et al. | Randomized controlled trial |
Immediate implants in the anterior maxilla of 90 patients Control group and implants pretreated with platelet-rich plasma (PRP group) or photofunctionalization (PF group) UV radiation of wavelength 253.7 nm in an ultraviolet ray chamber (SK Dent) for 20 min |
Pretreatment with PF or PRP: statistically significant difference only in implant stability but not in other parameters (including marginal bone loss, pink/white aesthetic score and success/survival rate) |
| II. Orthopedics | |||
| Tominaga H et al. | Prospective study |
13 patients underwent lumbar fusion Prospace intervertebral cage (B-Braun Company, Germany) UV using a low-pressure mercury lamp (TheraBeam Affiny; Ushio Inc. Himeji, Japan): for 15 min wavelength of 254 nm and 9.5 mW/cm2 |
To change the surface hydrophilic from hydrophobic To decrease the amount of carbon attached on the cage No significant difference between the degree of osteosclerosis between titanium cages with UV and without UV treatment Note: UV photofunctionalization in spine surgery is questionable. |
BIC: bone-to-implant contact; CBCT: cone-beam computed tomography; CT: computed tomography; ISQ: implant stability quotients; HU: Hounsfield unit; OSI, osseointegration speed index; PhF, photofunctionalization; RT, removal torque; UV, ultraviolet.